The FDA is reviewing 12 peptides for removal from its restricted listincluding BPC 157, TB 500, Semax, and GHK Cu. If it goes through, it's the biggest peptide policy shift in years. More access. Easier RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion BPC 157 Ulcerative Colitis LIVV Natural The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York